Full kinetic modeling analysis of [18F]fluorocholine Positron Emission Tomography (PET) at initial diagnosis of high-grade glioma.

PURPOSE: The main objective was to characterize the tracer uptake kinetics of [18F]fluoromethylcholine ([18F]F-CHO) in high-grade gliomas (HGG) through a full PET kinetic modeling approach. Secondarily, we aimed to explore the relationship between the PET uptake measures and the HGG molecular features. MATERIALS AND METHODS: Twenty-four patients with a suspected diagnosis of HGG were prospectively included. They underwent a dynamic brain [18F]F-CHO-PET/CT, from which a tumoral time-activity curve was extracted. The plasma input function was obtained through arterial blood sampling with metabolite correction. These data were fitted to 1- and 2-tissue-compartment models, the best of which was selected through the Akaike information criterion. We assessed the correlation between the kinetic parameters and the conventional static PET metrics (SUVmax, SUVmean and tumor-to-background ratio TBR). We explored the association between the [18F]F-CHO-PET quantitative parameters and relevant molecular biomarkers in HGG. RESULTS: Tumoral time-activity curves in all patients showed a rapid rise of [18F]F-CHO uptake followed by a plateau-like shape. Best fits were obtained with near-irreversible 2-tissue-compartment models. The perfusion-transport constant K1 and the net influx rate Ki showed strong correlation with SUVmax (r = 0.808-0.861), SUVmean (r = 0.794-0.851) and TBR (r = 0.643-0.784), p < 0.002. HGG was confirmed in 21 patients, of which those with methylation of the O-6-methylguanine-DNA methyltransferase (MGMT) gene promoter showed higher mean Ki (p = 0.020), K1 (p = 0.025) and TBR (p = 0.001) than the unmethylated ones. CONCLUSION: [18F]F-CHO uptake kinetics in HGG is best explained by a 2-tissue-compartment model. The conventional static [18F]F-CHO-PET measures have been validated against the perfusion-transport constant (K1) and the net influx rate (Ki) derived from kinetic modeling. A relationship between [18F]F-CHO uptake rate and MGMT methylation is suggested but needs further confirmation.

Zigzag vs Helicoidal Gold-Silver 1D Chains: Influence of Subtle Interactions in the Spatial Arrangement of Supramolecular Systems.

The reaction of 4'-(2-thienyl)-2,2':6',2,2''-terpyridine (S-terpy) with the heterometallic complexes [Au2Ag2R4(OEt2)2]n (R = C6F5, C6Cl5) leads to the compounds [{Au(C6X5)2}Ag(S-terpy)]n (X = F (1), Cl (2)). The X-ray diffraction analysis of the complexes shows an alternating disposition of the metals -Au-Ag-Au-Ag- in 1D infinite polymeric chains. Despite the fact of having the same metallic sequence, the spatial arrangement observed for both complexes is very different, since for [{Au(C6F5)2}Ag(S-terpy)]n (1) the metals adopt a zigzag disposition, whereas an helicoidal distribution of the interacting metals is observed for the complex [{Au(C6Cl5)2}Ag(S-terpy)]n (2). These different arrangements are related to the perhalophenyl ligands present in the complexes, which appear with different spatial dispositions, being staggered in the case of C6F5 (1) and almost eclipsed in the case of C6Cl5 (2). In order to explain the reasons for these different structural arrangements, we performed a DFT-D3 computational analysis and a subsequent study of the qualitative characterization of the noncovalent interactions (NCIs) in real space.

Fast-response flow-based method for evaluating 131I from biological and hospital waste samples exploiting liquid scintillation detection.

This paper presents a fast and automatic flow-based method to extract 131I from biological samples and hospital waste, previous to liquid scintillation detection. 131I is a radionuclide extensively used in Nuclear Medicine due to their beta and gamma disintegrations, whereby hospitals have to manage the associated waste generation. The automatic developed system is based on Lab-On-Valve (LOV) flow-technique exploiting Cl-resin (135 mg per extraction). This methodology allows performing sample extractions and measurements on the same day, since the extraction frequency takes 1.4-4 h-1, depending on the analysed sample volume, plus up to 2 h of measurement for each vial. 131I is retained as iodine ion and eluted with sodium sulphide 0.2 mol L-1. The maximum sample volume that can be preconcentrated is 20 mL, reaching an extraction efficiency of 85 ±â€¯5%. The minimum detectable activity (MDA) is 0.05 Bq, showing a precision of 7% RSD (n = 5). Both, biological samples (urine and saliva) and hospital waste samples can be satisfactorily analysed by the proposed system, obtaining recoveries between 90 and 110%. The developed method is then suitable to implement in hospitals, improving the surveillance of the 131I environmental release.

Development of a thin layer chromatography method for plasma correction of [18F]fluorocholine metabolites in positron emission tomography quantification studies in humans.

INTRODUCTION: After its intravenous injection, [18F]fluorocholine is oxidized by choline-oxidase into its main plasma metabolite, [18F]fluorobetaine. If PET kinetic modeling quantification of [18F]fluorocholine uptake is intended, the plasma input time-activity-curve of the parent tracer must be obtained, i.e., the fraction of the total plasma radioactivity corresponding to the nonmetabolized [18F]fluorocholine at each time has to be known. Hence our aim was to develop an easy-routine Thin-Layer-Chromatography (TLC) method to separate and quantify the relative fractions of [18F]fluorocholine and [18F]fluorobetaine as a function of time during PET imaging in humans. METHODS: First, we tested several combinations of solvents systems and layers to select the one showing the best resolution on non-radioactive standards. Thereafter, [18F]fluorobetaine was obtained through chemical oxidation of an [18F]fluorocholine sample at diferent incubation times and we applied the selected TLC-system to aliquots of this oxidation solution, both in a saline and in human deproteinized plasma matrices. The plates were detected by a radio-TLC-scanner. This TLC-system was finally applied to arterial plasma samples from 9 patients with high-grade-glioma undergoing brain PET imaging and a parent fraction curve was obtained in each of them. RESULTS: A TLC-system based on Silica-Gel-60//MeOH-NH3 was selected from the choline/betaine non-radioactive standards assay. Radiochromatograms of [18F]fluorocholine oxidation solution yielded two separated and well-defined peaks, Rf = 0,03 ([18F]fluorocholine) and Rf = 0.78 (18F]fluorobetaine) consistent with those observed on non-radioactive standards. During the oxidation, the [18F]fluorocholine radioactivity peak decreased progressively at several incubation times, while the other peak ([18F]fluorobetaine) increased accordingly. The mean values of the parent fraction of [18F]fluorocholine of the 9 patients studied (mean+/-SD) were 94% ±â€¯6%, 58% ±â€¯15%, 43% ±â€¯10%, 39% ±â€¯6% and 37% ±â€¯6% at 2.8 min, 5.8 min, 8.8 min, 11.7 min and 14.7 min post-injection, respectively. CONCLUSIONS: We have developed a TLC-system, easy to perform in a standard radiopharmacy unit, that enables the metabolite correction of arterial input function of [18F]fluorocholine in patients undergoing PET oncologic quantitative imaging.

Fully Automated System for 99Tc Monitoring in Hospital and Urban Residues: A Simple Approach to Waste Management.

99Tc is an artificial beta emitter widely used in nuclear medicine for diagnostic tests. A fully automated and rapid system for 99Tc monitoring is introduced with the aim to improve hospital residues management. This system can also be helpful for controlling urban wastewater. Figures of merit similar to those obtained with liquid scintillation counting were achieved by exploiting a simple, economic, and portable system with spectrophotometric detection. The combination of flow analysis techniques, i.e., lab-on-valve (LOV) and multisyringe flow injection analysis (MSFIA), with a selective resin ((weak base extraction chromatographic (WBEC) resin) enables the analysis to be performed in a short time, achieving high selectivity and sensitivity levels. After elution with NH4OH (3 mol·L-1), 99Tc is derivatized with 1,5-diphenylcarbohydrazide (DPC) and finally detected by a miniaturized fiber optic CCD spectrophotometer at 520 nm, exploiting a long path-length liquid waveguide capillary cell (LWCC) of 100 cm path length. The proposed method was optimized by experimental design, achieving a limit of detection (LOD) of 4 ng of 99Tc (2.5 Bq), a reproducibility of 6%, and a resin durability of 78 injections. The microcolumn allows one to preconcentrate up to 100 mL of sample without deterioration of the analytical signal. The automated system was successfully applied to hospital residues and urban wastewater, and the attained recoveries were between 90% and 110%.

Automatic in-syringe dispersive liquid-liquid microextraction of 99Tc from biological samples and hospital residues prior to liquid scintillation counting.

A new approach exploiting in-syringe dispersive liquid-liquid microextraction (DLLME) for (99)Tc extraction and preconcentration from biological samples, i.e., urine and saliva, and liquid residues from treated patients is presented. (99)Tc is a beta emitter with a long half-life (2.111 × 10(5) years) and mobility in the different environmental compartments. One of the sources of this radionuclide is through the use of its father (99m)Tc in medical diagnosis. For the first time a critical comparison between extractants and disperser solvents for (99)Tc DLLME is presented, e.g., tributyl phosphate (TBP), trioctylmethylammonium chloride (Aliquat®336), triisooctylamine (TiOA), as extractants in apolar solvents such as xylene and dodecane, and disperser solvents such as acetone, acetonitrile, ethanol, methanol, 1-propanol, and 2-propanol. The system was optimized by experimental design, and 22.5% of Aliquat®336 in acetone was selected as extractant and disperser, respectively. Off-line detection was performed using a liquid scintillation counter. The present method has a (99)Tc minimum detectable activity (MDA) of 0.075 Bq with a high extraction/preconcentration frequency (8 h(-1)). Urine, saliva, and hospital residues were satisfactorily analyzed with recoveries of 82-119%. Thus, the proposed system is an automatic powerful tool to monitor the entry of (99)Tc into the environment. Graphical Abstract (99m)Tc is widely used in Nuclear Medicine for diagnosis. Its daugther (99)Tc is automatically monitored in biological samples from treated patients by in-syringe dispersive liquid-liquid microextraction.

Automatic and simple method for 99Tc determination using a selective resin and liquid scintillation detection applied to urine samples.

(99m)Tc (6.0067 h half-life) is an artificial radionuclide largely used in diagnostic medicine. Its daughter (99)Tc is a beta emitter of great concern because of its long half-life (2.111 × 10(5) years) and presumed mobile behavior in the environment. To monitor the (99)Tc in urine from treated patients, an automatic Lab-on-valve (LOV) system for separation and preconcentration of (99)Tc was developed. TEVA resin was selected since it retains pertechnetate ion selectively from diluted nitric acid solutions. After elution, (99)Tc is detected using a liquid scintillation counting (LSC) detector. The present method has been successfully applied to urine samples with low (99)Tc content (recoveries between 94-111%). The minimum detectable activity (MDA) of the developed method is 0.1 Bq or 1 Bq L(-1) (expressed as activity concentration), when preconcentrating 100 mL of sample. The high durability of the resin, together with the low amount of resin required (32 mg), the good reproducibility (RSD 2%, n = 5) and the high extraction frequency (up to 12 h(-1)) makes of the present method an inexpensive, precise and fast useful tool for monitoring (99)Tc in urine samples.